États-Unis · Bourse & Finance · The Motley Fool

AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.

Publié par The Motley Fool · États-Unis il y a 8 h

Earlier this week, the U.S. Food and Drug Administration (FDA) approved AbbVie 's ( ABBV +1.11%) Juvmo (tavapadon). This is a once-daily pill for adults with Parkinson's disease…

Lire l'article complet sur The Motley Fool Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com)

AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.

À lire aussi

Top Performing Stocks

Ramp's Broadway musical was the worst show I've ever seen. I'm still glad it exists.

10 U.S. cities where it takes the biggest paycheck to buy a home

Trump Says Economy Has ‘Public Relations’ Problem Amid High Prices and Slow Hiring

America’s data center fight is a preview of what's to come for the rest of the world

‘Don’t Screw Up Your Rollover’: Before rolling over your 401(k), check withdrawal options, tax breaks you could be giving up

AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.

Partager

À lire aussi

Top Performing Stocks

Ramp's Broadway musical was the worst show I've ever seen. I'm still glad it exists.

10 U.S. cities where it takes the biggest paycheck to buy a home

Trump Says Economy Has ‘Public Relations’ Problem Amid High Prices and Slow Hiring

America’s data center fight is a preview of what's to come for the rest of the world

‘Don’t Screw Up Your Rollover’: Before rolling over your 401(k), check withdrawal options, tax breaks you could be giving up